Vitamin D replacement therapy in patients with pulmonary Hypertensio
Not Applicable
- Conditions
- Pulmonary Hypertention.Pulmonary heart disease and diseases of pulmonary circulation126-128
- Registration Number
- IRCT2013091713828N3
- Lead Sponsor
- Islamic Azad University,Najafabad branch,Isfahan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Inclusion Criteria:
History of Pulmonary Hypertension(Mean PAP more than 25mmHg by cardiac Catheterization);Presence of Vitamin D deficiency;Not using Vitamin D supplements before intervention;Patient's content
Exclusion Criteria
Adverse reaction of medication during the intervention;Failing of patient to keep on the trial
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 6 Minute Walk Test. Timepoint: Before intervention and also after normalization of plasma level of Vitamin D. Method of measurement: This test measures the distance that a patient can quickly walk on a flat, hard surface in a period of 6 minutes.;Pro-BNP. Timepoint: Before intervention and also after normalization of plasma level of Vitamin D. Method of measurement: Chimiluminescence.;Pulmonary Artery Pressure. Timepoint: Before intervention and also after normalization of plasma level of Vitamin D. Method of measurement: By Echocardiography and if need Right Heart catheterization.
- Secondary Outcome Measures
Name Time Method Plasma level of Vitamin D. Timepoint: Before intervention and 3 months after treatment and if need 6 months later. Method of measurement: Chimiluminescence.